302.45
Overview
News
Price History
Option Chain
Financials
Why ELV Down?
Discussions
Forecast
Stock Split
Dividend History
Elevance Health Inc stock is traded at $302.45, with a volume of 7.39M.
It is down -12.22% in the last 24 hours and down -19.39% over the past month.
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of December 2024. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
See More
Previous Close:
$344.55
Open:
$334
24h Volume:
7.39M
Relative Volume:
4.00
Market Cap:
$68.33B
Revenue:
$183.12B
Net Income/Loss:
$5.92B
P/E Ratio:
11.80
EPS:
25.63
Net Cash Flow:
$3.67B
1W Performance:
-12.55%
1M Performance:
-19.39%
6M Performance:
-21.50%
1Y Performance:
-41.94%
Elevance Health Inc Stock (ELV) Company Profile
Name
Elevance Health Inc
Sector
Industry
Phone
(800) 331-1476
Address
220 VIRGINIA AVENUE, INDIANAPOLIS
Compare ELV with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
ELV
Elevance Health Inc
|
302.45 | 78.14B | 183.12B | 5.92B | 3.67B | 25.63 |
![]()
UNH
Unitedhealth Group Inc
|
288.07 | 271.70B | 410.06B | 22.11B | 24.86B | 23.88 |
![]()
CVS
Cvs Health Corp
|
63.30 | 83.01B | 378.96B | 5.28B | 5.94B | 4.19 |
![]()
CI
Cigna Group
|
298.28 | 82.49B | 254.47B | 5.03B | 6.01B | 18.06 |
![]()
HUM
Humana Inc
|
223.55 | 28.02B | 117.76B | 1.21B | 2.39B | 9.95 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Apr-15-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
Mar-17-25 | Upgrade | Argus | Hold → Buy |
Jan-22-25 | Downgrade | Stephens | Overweight → Equal-Weight |
Oct-18-24 | Downgrade | Argus | Buy → Hold |
Jul-18-24 | Downgrade | BofA Securities | Buy → Neutral |
Jun-24-24 | Initiated | Morgan Stanley | Overweight |
May-30-24 | Initiated | Robert W. Baird | Outperform |
Mar-06-24 | Initiated | Barclays | Overweight |
Jul-12-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
Apr-27-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
Mar-28-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
Sep-09-22 | Upgrade | BofA Securities | Neutral → Buy |
Aug-22-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
View All
Elevance Health Inc Stock (ELV) Latest News
Class Claims Target Anthem's 'Ghost' Provider Networks - Law360
Leerink Downgrades Elevance Health (ELV) Rating Amid Earnings Concerns | ELV Stock News - GuruFocus
Elevance Stock Faces Headwinds After Q2 EPS Miss and Margin Compression - Investing.com
Elevance Health Tumbles After Slashing 2025 Outlook on Medicaid Weakness - Yahoo Finance
Elevance Health, Inc. SEC 10-Q Report - TradingView
Wall Street Worries a Health Insurance Meltdown Is Far From Over - Bloomberg
Medicaid, ACA costs will keep rising — and this insurer’s stock is tumbling - MSN
Elevance cuts outlook amid high exchange, Medicaid expenses - Modern Healthcare
Elevance Health: Q2 Earnings Snapshot - CTPost
Top Stock Movers Now: PepsiCo, Elevance Health, CSX, and More - Investopedia
Elevance Health (ELV) Stock Trades Down, Here Is Why - Yahoo Finance
Elevance lowers profit outlook, warns things will get worse for health insurers - STAT
Elevance Health Q2 Earnings Miss Estimates on Rising Medical Costs - Zacks Investment Research
Elevance Health (ELV) Updates 2025 EPS Guidance Amid Market Challenges - GuruFocus
Elevance Health Enters Oversold Territory - Nasdaq
Elevance Health, Inc. 2025 Q2ResultsEarnings Call Presentation (NYSE:ELV) - Seeking Alpha
Elevance Health (ELV) Drops 7% Premarket Amid Mixed Q2 Results - GuruFocus
Elevance's Local Market Leadership in Medical Insurance Sets It Apart From MCO Peers - Morningstar
UBS Lowered Firm’s PT on Elevance Health (ELV), Kept a Buy Rating - Insider Monkey
Elevance Stock Falls 11% After Earnings. What It Means for UnitedHealth, Other Insurers. - Barron's
Elevance Health (ELV) Stock Declines Over 11% | ELV Stock News - GuruFocus
Elevance Health just delivered terrifying news to investors - rollingout.com
Elevance Health Hit By Medicaid Troubles, Trims Outlook - Yahoo Finance
Elevance Health (ELV) Updates 2025 Earnings Forecast Amid Cost Challenges - GuruFocus
Earnings call transcript: Elevance Health’s Q2 2025 EPS misses forecast, stock drops - Investing.com
Elevance cuts forecast as rising costs hit health insurers - Reuters
Elevance Health (ELV) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Wells Fargo & Company Lowers Elevance Health (NYSE:ELV) Price Target to $400.00 - Defense World
Elevance Health Stock Slips Pre-Market After Slashing Full-Year Earnings Guidance: Retail Now Eyes UnitedHealth Q2 Results - MSN
Elevance Health Stock Slips Pre-Market After Slashing Full-Year Earnings Guidance: Retail Now Eyes UnitedHealth Q2 Results By Stocktwits - Investing.com India
Elevance's forecast cut magnifies medical cost woes for US health insurers - Reuters
Elevance cuts 2025 guidance as profit falls from higher ACA, Medicaid costs - Yahoo Finance
Elevance Health (ELV) Falls Short of Expectations with Q2 ’25 Results - Tokenist
Elevance Cuts Outlook as Higher Costs Weigh on Industry - Bloomberg.com
Elevance's forecast cut signals deeper struggles for US health insurers - Reuters
Elevance Health lowers 2025 guidance amid cost pressures in ACA, Medicaid markets - Fierce Healthcare
Elevance Health Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Elevance Health stock falls after guidance cut (ELV:NYSE) - Seeking Alpha
Elevance Health (NYSE:ELV) Beats Q2 Sales Targets - TradingView
Elevance Health Q2 2025 Earnings: EPS of $8.84 Beats Estimates, Revenue Surpasses Expectations at $49.4 Billion - GuruFocus
Elevance Health Is Latest Insurer To Cut Profit Targets As Costs Surge - Forbes
Earnings Snapshot: Elevance Health profit outlook misses estimates, stock drops (ELV:NYSE) - Seeking Alpha
Elevance Health's Q2 2025 Earnings: Navigating Margin Pressures and Strategic Gains - AInvest
Elevance Health (ELV) Adjusts 2025 Earnings Expectations Amid Co - GuruFocus
Elevance Health Reports Second Quarter 2025 Results - TradingView
Elevance Health: Much Cheaper Than UNH, Yet No Drama (ELV) - Seeking Alpha
Truist Securities Updates Price Target for Elevance Health (ELV) | ELV Stock News - GuruFocus
Truist Adjusts Price Target for Elevance Health (ELV) Amid Secto - GuruFocus
MU Health Care, Anthem Blue Cross reach agreement to restore in-network access for members - Jefferson City News Tribune
Elevance Health (NYSE:ELV) Earns Buy Rating from UBS Group - Defense World
Elevance Health (ELV) Reports Earnings Tomorrow: What To Expect - Yahoo Finance
Elevance Health Inc Stock (ELV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):